Safety and Efficacy of Vaccines during COVID-19 Pandemic in Patients Treated with Biological Drugs in a Dermatological Setting

The BNT162b2 and mRNA-1273 vaccines, consisting of mRNA, have recently become available. The absolute novelty of these vaccines introduces questions about their safety and efficacy, especially in patients who are treated with biological drugs in dermatology. The aim of our review was to provide a br...

Descripción completa

Detalles Bibliográficos
Autores principales: Simonetti, Oriana, Rizzetto, Giulio, Molinelli, Elisa, Diotallevi, Federico, Radi, Giulia, Cirioni, Oscar, D’Errico, Marcello Mario, Offidani, Annamaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067116/
https://www.ncbi.nlm.nih.gov/pubmed/33916122
http://dx.doi.org/10.3390/healthcare9040401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067116/
https://www.ncbi.nlm.nih.gov/pubmed/33916122
http://dx.doi.org/10.3390/healthcare9040401

Ejemplares similares